TY - JOUR
T1 - Lyon IARC Polyomavirus Displays Transforming Activities in Primary Human Cells
AU - Venuti, Assunta
AU - Romero-Medina, Maria Carmen
AU - Melita, Giusi
AU - Ceraolo, Maria Grazia
AU - Brancaccio, Rosario Nicola
AU - Sirand, Cecilia
AU - Taverniti, Valerio
AU - Steenbergen, Renske
AU - Gheit, Tarik
AU - Tommasino, Massimo
N1 - Funding Information:
The study was supported by a grant from Fondation ARC pour la recherche sur le cancer (no. PJA 20151203192) (https://www.fondation-arc.org/espace-chercheur) and the Institut National de la Santé et de la Recherche Médicale (no. ENV201610) (https:// www.eva2.inserm.fr/EVA/jsp/AppelsOffres/CANCER/) to M.T.
Publisher Copyright:
Copyright © 2022 American Society for Microbiology. All Rights Reserved.
PY - 2022/7/1
Y1 - 2022/7/1
N2 - Several studies reported the presence of a recently discovered polyomavirus (PyV), Lyon IARC PyV (LIPyV), in human and domestic animal specimens. LIPyV has some structural similarities to well-established animal and human oncogenic PyVs, such as raccoon PyV and Merkel cell PyV (MCPyV), respectively. In this study, we demonstrate that LIPyV early proteins immortalize human foreskin keratinocytes. LIPyV LT binds pRb, accordingly cell cycle checkpoints are altered in primary human fibroblasts and keratinocytes expressing LIPyV early genes. Mutation of the pRb binding site in LT strongly affected the ability of LIPyV ER to induced HFK immortalization. LIPyV LT also binds p53 and alters p53 functions activated by cellular stresses. Finally, LIPyV early proteins activate telomerase reverse transcriptase (hTERT) gene expression, via accumulation of the Sp1 transcription factor. Sp1 recruitment to the hTERT promoter is controlled by its phosphorylation, which is mediated by ERK1 and CDK2. Together, these data highlight the transforming properties of LIPyV in in vitro experimental models, supporting its possible oncogenic nature.
AB - Several studies reported the presence of a recently discovered polyomavirus (PyV), Lyon IARC PyV (LIPyV), in human and domestic animal specimens. LIPyV has some structural similarities to well-established animal and human oncogenic PyVs, such as raccoon PyV and Merkel cell PyV (MCPyV), respectively. In this study, we demonstrate that LIPyV early proteins immortalize human foreskin keratinocytes. LIPyV LT binds pRb, accordingly cell cycle checkpoints are altered in primary human fibroblasts and keratinocytes expressing LIPyV early genes. Mutation of the pRb binding site in LT strongly affected the ability of LIPyV ER to induced HFK immortalization. LIPyV LT also binds p53 and alters p53 functions activated by cellular stresses. Finally, LIPyV early proteins activate telomerase reverse transcriptase (hTERT) gene expression, via accumulation of the Sp1 transcription factor. Sp1 recruitment to the hTERT promoter is controlled by its phosphorylation, which is mediated by ERK1 and CDK2. Together, these data highlight the transforming properties of LIPyV in in vitro experimental models, supporting its possible oncogenic nature.
KW - Lyon IARC polyomavirus
KW - Sp1 transcription factor
KW - cellular transformation
KW - hTERT activation
KW - p53 and pRb
UR - http://www.scopus.com/inward/record.url?scp=85135206296&partnerID=8YFLogxK
U2 - 10.1128/jvi.02061-21
DO - 10.1128/jvi.02061-21
M3 - Article
C2 - 35770990
SN - 0022-538X
VL - 96
JO - Journal of Virology
JF - Journal of Virology
IS - 14
ER -